Loading clinical trials...
Loading clinical trials...
This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pharmicell Co., Ltd.
NCT06840652 · Alcoholic Cirrhosis, Alcohol Abstinence, and more
NCT03508388 · Alcoholic Cirrhosis, Alcoholic Liver Disease
NCT01065233 · Alcoholic Cirrhosis
NCT01342705 · Alcoholic Cirrhosis, Iron Overload
Soonchunhyang University Hospital
Bucheon-si
Soonchunhyang University Hospital
Cheonan
Gangwon National University Hospital
Chuncheon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions